Aethlon Medical, Inc.
AEMD
$4.21
-$0.23-5.18%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.48M | 1.79M | 2.00M | 1.81M | 2.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.48M | 1.79M | 2.00M | 1.81M | 2.90M |
| Operating Income | -1.48M | -1.79M | -2.00M | -1.81M | -2.90M |
| Income Before Tax | -1.49M | -1.76M | -6.25M | -1.75M | -2.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.49M | -1.76M | -6.25M | -1.75M | -2.81M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.49M | -1.76M | -6.25M | -1.75M | -2.81M |
| EBIT | -1.48M | -1.79M | -2.00M | -1.81M | -2.90M |
| EBITDA | -1.40M | -1.71M | -1.92M | -1.73M | -2.82M |
| EPS Basic | -3.74 | -8.49 | -34.41 | -10.05 | -16.11 |
| Normalized Basic EPS | -2.29 | -5.30 | -21.51 | -6.28 | -10.07 |
| EPS Diluted | -3.74 | -8.49 | -34.41 | -10.05 | -16.11 |
| Normalized Diluted EPS | -2.29 | -5.30 | -21.51 | -6.28 | -10.07 |
| Average Basic Shares Outstanding | 397.50K | 207.60K | 181.80K | 174.50K | 174.20K |
| Average Diluted Shares Outstanding | 397.50K | 207.60K | 181.80K | 174.50K | 174.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |